LSP Invests In Cardiac Dimensions, A Pioneer In Heart Failure Treatment

Amsterdam, the Netherlands, March 13 2015. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in Cardiac Dimensions, a private company commercializing the Carillon Mitral Contour System. This implantable device is designed to treat heart failure patients suffering from a dysfunctional mitral valve. LSP expects that this device will improve the quality of life of many heart failure patients and will simultaneously result in cost reductions thanks to a decrease in the number of re-hospitalizations. A PDF version of Cardiac Dimensions’ press release can be found here.

About LSP

LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over USD 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors. For more information, please visit lspvc.com.

For more information, please contact:

Rudy Dekeyser, Managing Partner LSP HEF
Tel: +31 20 664 5500
rdekeyser@lspvc.com
lspvc.com

Help employers find you! Check out all the jobs and post your resume.

Back to news